Welcome to this fortnight's SMEDTEC Intelligence. The dominant theme is the MHRA's assertive repositioning: a record-performance annual report, freshly published economic-growth goals, refreshed guidance on custom-made devices and approved bodies, and updated IVD point-of-care guidance. Across the Atlantic, the MDUFA VI draft agreement is setting expectations for FDA device-review performance through 2032. Meanwhile, two rounds of UK Field Safety Notices and a sterility-breach recall are timely reminders to audit post-market surveillance workflows. Read on for your curated briefing.
The fortnight in numbers
By market
By regulator
Competitor approvals · last 30 days
By regulator
By market
MHRA · UK
The MHRA has formalised government-agreed goals tying its regulatory actions to UK economic growth. For small/mid device manufacturers, this signals faster approvals, proactive engagement and a more commercially minded regulator — but also heightened scrutiny on whether submissions meet quality thresholds. Review how your UKCA roadmap aligns with the agency's new performance commitments.
Read the source →MHRA · UK
The MHRA's annual report reveals accelerated review timelines, expanded international recognition partnerships and a growing approved-body network. Regulatory affairs teams should note throughput metrics and any shifts in inspection priorities that could affect time-to-market for UKCA submissions. The report also provides evidence-based benchmarks for setting realistic registration timelines with clients.
Read the source →MHRA · UK
The updated list of UK Approved Bodies for medical device conformity assessments is critical for manufacturers holding or pursuing UKCA certification. Any addition, suspension or scope change affects which body can certify your device class. Cross-reference this list against your current or planned Approved Body agreements, particularly if you are mid-audit or approaching certificate renewal.
Read the source →MHRA · UK
Updated MHRA guidance clarifies the full compliance pathway for custom-made devices under UKCA — covering statements of manufacture, clinical evaluation, traceability and registration obligations. Manufacturers in orthotics, prosthetics, dental and bespoke implant sectors must confirm their QMS and documentation practices align with this refreshed framework before UKCA transition deadlines bite.
Read the source →MHRA · UK
This refreshed MHRA publication details the specific regulatory obligations applicable to prosthetic, orthotic and ophthalmic medical devices in Great Britain. Manufacturers in these categories should review the updated requirements alongside the custom-device guidance above, as together they represent a meaningful tightening of UKCA compliance expectations for specialist device types.
Read the source →MHRA · UK
Refreshed MHRA guidance on in vitro diagnostic point-of-care testing devices covers management, use and regulatory expectations. With IVDR-equivalent requirements tightening under UKCA, IVD manufacturers and distributors supplying near-patient or decentralised testing settings should review this document to confirm labelling, performance evaluation and post-market surveillance obligations are met.
Read the source →INDUSTRY · GLOBAL
The draft MDUFA VI agreement sets FDA's performance goals for medical device reviews over the next user-fee cycle. Early signals include revised timelines for 510(k), De Novo and PMA pathways, and potential changes to pre-submission interaction. Small/mid manufacturers should engage in the public comment process and begin modelling how revised review timelines affect US launch planning and resource allocation.
Read the source →MHRA · UK
MHRA published Field Safety Notices for both 6–10 July and 13–17 July 2026. Post-market surveillance leads should review both batches to identify any devices overlapping with your portfolio or supply chain, assess whether corrective action triggers apply under your vigilance procedures, and confirm FSCA reporting obligations to MHRA and, where applicable, EU/FDA competent authorities.
Read the source →Get this in your inbox
Built by SMEDTEC OS
The regulatory operating system for the medical device supply chain.